Mingyuan Wang

1.2k total citations
60 papers, 939 citations indexed

About

Mingyuan Wang is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Mingyuan Wang has authored 60 papers receiving a total of 939 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 17 papers in Cancer Research and 9 papers in Oncology. Recurrent topics in Mingyuan Wang's work include Advanced biosensing and bioanalysis techniques (12 papers), MicroRNA in disease regulation (8 papers) and Cancer-related molecular mechanisms research (7 papers). Mingyuan Wang is often cited by papers focused on Advanced biosensing and bioanalysis techniques (12 papers), MicroRNA in disease regulation (8 papers) and Cancer-related molecular mechanisms research (7 papers). Mingyuan Wang collaborates with scholars based in China, United States and New Zealand. Mingyuan Wang's co-authors include Peng Miao, Yanzheng Gu, Xueguang Zhang, Xiangping Song, Wei Wu, Yayun Nan, Qiaohui Chen, Benkui Tan, Tianjiao Zhao and Kelong Ai and has published in prestigious journals such as Advanced Materials, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Mingyuan Wang

56 papers receiving 924 citations

Peers

Mingyuan Wang
Meng Du China
Suresh Kumar Balasubramanian United States
Vladimir Jurukovski United States
Ningning He China
David A. Glesne United States
Donglin Liu China
Dan Wei China
Jing Ge China
Dongyan Wang China
Di Cui China
Meng Du China
Mingyuan Wang
Citations per year, relative to Mingyuan Wang Mingyuan Wang (= 1×) peers Meng Du

Countries citing papers authored by Mingyuan Wang

Since Specialization
Citations

This map shows the geographic impact of Mingyuan Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mingyuan Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mingyuan Wang more than expected).

Fields of papers citing papers by Mingyuan Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mingyuan Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mingyuan Wang. The network helps show where Mingyuan Wang may publish in the future.

Co-authorship network of co-authors of Mingyuan Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Mingyuan Wang. A scholar is included among the top collaborators of Mingyuan Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mingyuan Wang. Mingyuan Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Xie, Shuhong, Zhen Liu, Zhipeng Xu, et al.. (2025). Establishment and Clinical Application of Rh Blood Group Bank in the East China Region. International Journal of General Medicine. Volume 18. 717–724.
3.
Wang, Mingyuan, et al.. (2024). ALDH1A1 promotes immune escape of tumor cells through ZBTB7B-glycolysis pathway. Cell Death and Disease. 15(8). 568–568. 9 indexed citations
4.
Song, Xiangping, Qiong Huang, Yuqi Yang, et al.. (2023). Efficient Therapy of Inflammatory Bowel Disease (IBD) with Highly Specific and Durable Targeted Ta2C Modified with Chondroitin Sulfate (TACS). Advanced Materials. 35(36). e2301585–e2301585. 69 indexed citations
5.
Li, Yang, Wenwen Wang, Jingluan Tian, et al.. (2023). Clinical Significance of Soluble LAG-3 (sLAG-3) in Patients With Cervical Cancer Determined via Enzyme-Linked Immunosorbent Assay With Monoclonal Antibodies. Technology in Cancer Research & Treatment. 22. 2223944538–2223944538. 7 indexed citations
6.
Zhang, Xu, Ali Saber, Min Wei, et al.. (2023). Development and validation of a nomogram model for lung cancer based on radiomics artificial intelligence score and clinical blood test data. Frontiers in Oncology. 13. 1132514–1132514. 6 indexed citations
7.
Liu, Xiaoping, et al.. (2023). Curcumin: a natural organic component that plays a multi-faceted role in ovarian cancer. Journal of Ovarian Research. 16(1). 47–47. 16 indexed citations
8.
9.
10.
Wang, Mingyuan, Jiang Zou, Jinjin Wang, et al.. (2022). Aberrant HSF1 signaling activation underlies metformin amelioration of myocardial infarction in mice. Molecular Therapy — Nucleic Acids. 29. 312–328. 7 indexed citations
11.
Zheng, Wei, Mingyuan Wang, H. T. Blair, et al.. (2021). miR-509-5p anti-infection response for mycoplasma pneumonia in sheep by targeting NF-κB pathway. Veterinary Immunology and Immunopathology. 238. 110275–110275. 4 indexed citations
12.
Nan, Ying, Mingyuan Wang, Yanyan Shao, et al.. (2021). Comparative profiling of the resistance of different genotypes of mannose-binding lectin to Mycoplasma pneumoniae infection in Chinese Merino sheep based on high-throughput sequencing technology. Veterinary Immunology and Immunopathology. 233. 110183–110183. 3 indexed citations
13.
Wang, Mingyuan, et al.. (2020). Duplex-specific nuclease assisted miRNA assay based on gold and silver nanoparticles co-decorated on electrode interface. Analytica Chimica Acta. 1107. 23–29. 21 indexed citations
14.
Wang, Mingyuan, Yanyan Shao, Ying Nan, et al.. (2020). Characterization of muscle development and gene expression in early embryos of chicken, quail, and their hybrids. Gene. 768. 145319–145319. 21 indexed citations
15.
Wang, Mingyuan, et al.. (2020). TAF1A and ZBTB41 serve as novel key genes in cervical cancer identified by integrated approaches. Cancer Gene Therapy. 28(12). 1298–1311. 11 indexed citations
16.
Xue, Qun, Xiaoping Li, Yanzheng Gu, et al.. (2019). Unbalanced Expression of ICOS and PD-1 in Patients with Neuromyelitis Optica Spectrum Disorder. Scientific Reports. 9(1). 14130–14130. 11 indexed citations
17.
Li, Hongyan, Yi Zhu, Xiaoyan He, et al.. (2014). Mutation analysis of PARK2 in a Uyghur family with early-onset Parkinson's disease in Xinjiang, China. Journal of the Neurological Sciences. 342(1-2). 21–24. 5 indexed citations
18.
19.
Luan, Xiying, Guangbo Zhang, Gehua Yu, et al.. (2007). [Effects of MSC on cell cycle, phenotype and cytokine secretion of T cells activated by PHA].. PubMed. 23(5). 402–5. 1 indexed citations
20.
Wang, Mingyuan. (2000). Assessments of Environment Capacity andEcological Risk of Oasis in Ejina Desert Region. Ganhanqu ziyuan yu huanjing. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Meng Du Breakdown of academic impact, for papers by Suresh Kumar Balasubramanian Breakdown of academic impact, for papers by Vladimir Jurukovski Breakdown of academic impact, for papers by Ningning He Breakdown of academic impact, for papers by David A. Glesne Breakdown of academic impact, for papers by Donglin Liu Breakdown of academic impact, for papers by Dan Wei Breakdown of academic impact, for papers by Jing Ge Breakdown of academic impact, for papers by Dongyan Wang Breakdown of academic impact, for papers by Di Cui
Rankless by CCL
2026